GlassScriptPhysician profile
Michelle Marilyn Smith
NPI 1033602909
$2,254.06
in general payments reported to CMS, 2019-2025
16 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $352 · 2022: $842 · 2023: $472 · 2024: $293 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,042 · Travel and Lodging: $17.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,041.88 |
| Travel and Lodging | $17.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $941.36 | 2021-2022 | |
| Abbvie INC. | $717.16 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $133.65 | 2023-2024 | Ajovy |
| Jazz Pharmaceuticals INC. | $105.39 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $61.82 | 2025 | Ultomiris |
| Galderma Laboratories, L.P. | $61.49 | 2022-2025 | |
| Pfizer INC. | $37.79 | 2025 | |
| Merz Pharmaceuticals, LLC | $30.89 | 2021 | |
| Karl Storz Endoscopy-America | $27.93 | 2023 | Flex-X |
| Supernus Pharmaceuticals, INC. | $24.22 | 2022 | |
| Neuronetics, INC. | $21.34 | 2021 | |
| Genentech USA, INC. | $20.54 | 2025 | Ocrevus Zunovo |
| Myriad Genetic Laboratories, INC. | $20.52 | 2025 | Prolaris |
| Janssen Biotech, INC. | $17.80 | 2021 | |
| Emd Serono, INC. | $16.97 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $15.19 | 2025 | Zeposia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.